{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:46:36Z","timestamp":1793907996178,"version":"4.8.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["heartandlung.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.hrtlng.2023.10.001","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T23:18:51Z","timestamp":1696979931000},"page":"78-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effects of Antihypertensive Agents on the Clinical Outcome of Hospitalized COVID-19 Patients Concomitant with Hypertension: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"63","author":[{"given":"Jinfeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingtao","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanen","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrtlng.2023.10.001_bib0001","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/CIRCULATIONAHA.120.047022","article-title":"COVID-19 and renin angiotensin blockers: current evidence and recommendations","volume":"141","author":"Messerli","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0002","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","article-title":"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options","volume":"116","author":"Guzik","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0003","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(05)60114-6","article-title":"ACE inhibitors and pneumonia","volume":"352","author":"Sekizawa","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0004","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11427-015-4814-7","article-title":"Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse","volume":"58","author":"Yan","year":"2015","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0005","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jacc.2022.07.005","article-title":"Harmonization of the American college of cardiology\/American heart association and European society of cardiology\/European society of hypertension blood pressure\/Hypertension guidelines: comparisons, reflections, and recommendations","volume":"80","author":"Whelton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0006","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","article-title":"COVID-19 and cardiovascular disease","volume":"141","author":"Clerkin","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0007","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.620990","article-title":"Combination of angiotensin (1-7) agonists and convalescent plasma as a new strategy to overcome angiotensin converting enzyme 2 (ACE2) inhibition for the treatment of COVID-19","volume":"8","author":"Issa","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0009","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0011","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chest.2021.01.073","article-title":"Dihydropyridine calcium channel blockers and the risk of severe COVID-19","volume":"160","author":"Mendez","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0012","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/emph\/eoaa046","article-title":"Conflicts over calcium and the treatment of COVID-19","volume":"9","author":"Crespi","year":"2021","journal-title":"Evol Med Public Health"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0014","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ehjcvp\/pvaa056","article-title":"Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality","volume":"6","author":"Cannata","year":"2020","journal-title":"Euro Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ahj.2022.04.001","article-title":"Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: insights from the BRACE CORONA trial","volume":"249","author":"Macedo","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0016","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ahj.2022.01.015","article-title":"A randomized controlled trial of renin-angiotensin-aldosterone system inhibitor management in patients admitted in hospital with COVID-19","volume":"247","author":"Sharma","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0017","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/ajh\/hpaa149","article-title":"Effects of angiotensin receptor blockers (ARBs) on in-hospital outcomes of patients with hypertension and confirmed or clinically suspected COVID-19","volume":"33","author":"Soleimani","year":"2020","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0018","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10557-021-07155-5","article-title":"Association of antihypertensive agents with the risk of in-hospital death in patients with Covid-19","volume":"36","author":"Chouchana","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0019","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41421-020-00221-6","article-title":"Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients","volume":"6","author":"Yan","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-2600(20)30558-0","article-title":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial","volume":"9","author":"Cohen","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0021","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/infdis\/jiaa447","article-title":"Continued in-hospital angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use in hypertensive COVID-19 patients is associated with positive clinical outcome","volume":"222","author":"Lam","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0022","first-page":"25","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"100","author":"O'Rourke","year":"2009","journal-title":"Minerva Med"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0023","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators","volume":"350","author":"Staessen","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0024","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0025","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0026","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/jmv.26625","article-title":"The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: a systematic review and meta-analysis","volume":"93","author":"Wang","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0027","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41440-021-00786-z","article-title":"Clinical outcomes of hypertensive patients with COVID-19 receiving calcium channel blockers: a systematic review and meta-analysis","volume":"45","author":"Kow","year":"2022","journal-title":"Hypertens Res"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0028","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jash.2007.10.005","article-title":"Differential effect of low dose thiazides on the renin angiotensin system in genetically hypertensive and normotensive rats","volume":"2","author":"Jessup","year":"2008","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0029","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamacardio.2020.1282","article-title":"Coronavirus Disease 2019 (COVID-19) infection and renin angiotensin system blockers","volume":"5","author":"Bavishi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrtlng.2023.10.001_bib0030","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956323002443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956323002443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T03:31:04Z","timestamp":1731727864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956323002443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":30,"alternative-id":["S0147956323002443"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2023.10.001","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Antihypertensive Agents on the Clinical Outcome of Hospitalized COVID-19 Patients Concomitant with Hypertension: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2023.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}